作者
Johan L.K. Van Hove,Marisa W. Friederich,Dana Strode,Roxanne A. Van Hove,Kristen Campbell,Rohit Sharma,Hardik Shah,Jane Estrella,Linda Gabel,Simon Horslen,Rohit Kohli,Mark A. Lovell,Alexander Miethke,Jean P. Molleston,René Romero,James E. Squires,Estella M. Alonso,Maria Oliva‐Hemker,Binita M. Kamath,Kathleen M. Loomes,Philip Rosenthal,Krupa R. Mysore,Laurel Cavallo,Pamela L. Valentino,John C. Magee,Shikha S. Sundaram,Ronald J. Sokol
摘要
Mitochondrial hepatopathies (MHs) are primary mitochondrial genetic disorders that can present as childhood liver disease. No recognized biomarkers discriminate MH from other childhood liver diseases. The protein biomarkers growth differentiation factor 15 (GDF15) and fibroblast growth factor 21 (FGF21) differentiate mitochondrial myopathies from other myopathies. We evaluated these biomarkers to determine if they discriminate MH from other liver diseases in children.
PDF的下载单位、IP信息已删除
(2025-6-4)
tuanheqi
hanawang
zhu
殷勤的紫槐
GingerF
windy
null
大力的灵雁
无极微光
干净的琦
寻道图强
tiptip
子车茗
Twonej
嘿嘿
核潜艇很优秀
David
竹筏过海
小二郎
FrankD
皖公网安备34019202002308
